These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


523 related items for PubMed ID: 30980653

  • 1. Evaluating a New International Risk-Prediction Tool in IgA Nephropathy.
    Barbour SJ, Coppo R, Zhang H, Liu ZH, Suzuki Y, Matsuzaki K, Katafuchi R, Er L, Espino-Hernandez G, Kim SJ, Reich HN, Feehally J, Cattran DC, International IgA Nephropathy Network.
    JAMA Intern Med; 2019 Jul 01; 179(7):942-952. PubMed ID: 30980653
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. External Validation of the International IgA Nephropathy Prediction Tool in Older Adult Patients.
    Zhang Q, Zhang Q, Duan Z, Chen P, Chen JJ, Li MX, Zhang JJ, Huo YH, Zhang WX, Yang C, Zhang Y, Chen X, Cai G.
    Clin Interv Aging; 2024 Jul 01; 19():911-922. PubMed ID: 38799377
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Kidney Failure Risk Prediction Equations in IgA Nephropathy: A Multicenter Risk Assessment Study in Chinese Patients.
    Xie J, Lv J, Wang W, Li G, Liu Z, Chen H, Xu F, Sun J, Ouyang Y, Zhang X, Yang M, Shi M, Zhang W, Ren H, Kiryluk K, Zhang H, Chen N.
    Am J Kidney Dis; 2018 Sep 01; 72(3):371-380. PubMed ID: 29555434
    [Abstract] [Full Text] [Related]

  • 6. Prediction and Risk Stratification of Kidney Outcomes in IgA Nephropathy.
    Chen T, Li X, Li Y, Xia E, Qin Y, Liang S, Xu F, Liang D, Zeng C, Liu Z.
    Am J Kidney Dis; 2019 Sep 01; 74(3):300-309. PubMed ID: 31031086
    [Abstract] [Full Text] [Related]

  • 7. Use of Histologic Parameters to Predict Glomerular Disease Progression: Findings From the China Kidney Biopsy Cohort Study.
    Zhang X, Luo F, Chen R, Shen J, Liu X, Shi Y, Yang Q, Huang T, Li H, Hu Y, Wan Q, Chen C, Jia N, Cao Y, Li Y, Zhao H, Su L, Gao P, Xu X, Nie S, Hou FF.
    Am J Kidney Dis; 2023 Apr 01; 81(4):416-424.e1. PubMed ID: 36252881
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The MEST score provides earlier risk prediction in lgA nephropathy.
    Barbour SJ, Espino-Hernandez G, Reich HN, Coppo R, Roberts IS, Feehally J, Herzenberg AM, Cattran DC, Oxford Derivation, North American Validation and VALIGA Consortia, Oxford Derivation North American Validation and VALIGA Consortia.
    Kidney Int; 2016 Jan 01; 89(1):167-75. PubMed ID: 26759049
    [Abstract] [Full Text] [Related]

  • 14. Validation of the international IgA nephropathy prediction tool in a French cohort beyond 10 years after diagnosis.
    Bon G, Jullien P, Masson I, Sauron C, Dinic M, Claisse G, Pelaez A, Thibaudin D, Mohey H, Alamartine E, Mariat C, Maillard N.
    Nephrol Dial Transplant; 2023 Sep 29; 38(10):2257-2265. PubMed ID: 37316441
    [Abstract] [Full Text] [Related]

  • 15. An update on predicting renal progression in IgA nephropathy.
    Barbour S, Reich H.
    Curr Opin Nephrol Hypertens; 2018 May 29; 27(3):214-220. PubMed ID: 29432215
    [Abstract] [Full Text] [Related]

  • 16. A Validation Study Comparing Risk Prediction Models of IgA Nephropathy.
    Ouyang Y, Zhao Z, Li G, Luo H, Xu F, Shao L, Chen Z, Yu S, Jin Y, Xu J, Shi M, Hussain HMJ, Du W, Fang Z, Pan X, Wang W, Xie J, Chen N.
    Front Immunol; 2021 May 29; 12():753901. PubMed ID: 34721428
    [Abstract] [Full Text] [Related]

  • 17. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X, Shi S, Ouyang Y, Yang M, Shi M, Pan X, Lv J, Wang Z, Ren H, Shen P, Wang W, Zhang H, Xie J, Chen N.
    J Transl Med; 2018 May 03; 16(1):115. PubMed ID: 29724226
    [Abstract] [Full Text] [Related]

  • 18. Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy.
    Papasotiriou M, Stangou M, Chlorogiannis D, Marinaki S, Xydakis D, Sampani E, Lioulios G, Kapsia E, Zerbala S, Koukoulaki M, Moustakas G, Fokas S, Dounousi E, Duni A, Papadaki A, Damianakis N, Bacharaki D, Stylianou K, Gakiopoulou H, Liapis G, Sakellaropoulos G, Papachristou E, Boletis I, Papagianni A, Goumenos DS.
    Front Med (Lausanne); 2022 May 03; 9():778464. PubMed ID: 35242773
    [Abstract] [Full Text] [Related]

  • 19. Derivation and External Validation of Prediction Models for Advanced Chronic Kidney Disease Following Acute Kidney Injury.
    James MT, Pannu N, Hemmelgarn BR, Austin PC, Tan Z, McArthur E, Manns BJ, Tonelli M, Wald R, Quinn RR, Ravani P, Garg AX.
    JAMA; 2017 Nov 14; 318(18):1787-1797. PubMed ID: 29136443
    [Abstract] [Full Text] [Related]

  • 20. External validation of the pediatric International IgA Nephropathy Prediction Tool in a central China cohort.
    Ying D, Lu M, Zhi Y, Shi P, Cao L, Wang Q, Zhang Y, Zhang J.
    Clin Exp Nephrol; 2024 Jan 14; 28(1):59-66. PubMed ID: 37713045
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.